Valentina Tateo

719 total citations · 2 hit papers
36 papers, 437 citations indexed

About

Valentina Tateo is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Valentina Tateo has authored 36 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 22 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Valentina Tateo's work include Bladder and Urothelial Cancer Treatments (19 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Urinary and Genital Oncology Studies (11 papers). Valentina Tateo is often cited by papers focused on Bladder and Urothelial Cancer Treatments (19 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Urinary and Genital Oncology Studies (11 papers). Valentina Tateo collaborates with scholars based in Italy, United States and Netherlands. Valentina Tateo's co-authors include Francesco Massari, Veronica Mollica, Alessandro Rizzo, Matteo Santoni, Matteo Rosellini, Elisa Tassinari, Andrea Marchetti, Raffaella Massafra, Raffaele De Luca and Razelle Kurzrock and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Valentina Tateo

26 papers receiving 433 citations

Hit Papers

The impact of ECOG performance status on efficacy of immu... 2023 2026 2024 2025 2023 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study
    2023 115 citations Veronica Mollica, Alessandro Rizzo et al. profile →
  2. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study
    2023 107 citations Alessandro Rizzo, Veronica Mollica et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valentina Tateo Italy 10 205 150 114 106 96 36 437
Ann W. Gramza United States 10 200 1.0× 181 1.2× 137 1.2× 72 0.7× 52 0.5× 22 552
Darren M. Kocs United States 9 219 1.1× 137 0.9× 145 1.3× 109 1.0× 57 0.6× 16 402
Jinan Ma China 12 174 0.8× 101 0.7× 143 1.3× 42 0.4× 111 1.2× 43 397
Zhaofei Pang China 14 259 1.3× 169 1.1× 152 1.3× 62 0.6× 127 1.3× 29 506
Maria Antonietta Satolli Italy 14 293 1.4× 100 0.7× 116 1.0× 116 1.1× 85 0.9× 29 440
Fenglong Bie China 13 211 1.0× 155 1.0× 143 1.3× 48 0.5× 88 0.9× 32 429
Mitsuro Fukuhara Japan 12 247 1.2× 200 1.3× 110 1.0× 71 0.7× 113 1.2× 35 460
Matías Chacón Argentina 13 192 0.9× 191 1.3× 69 0.6× 100 0.9× 67 0.7× 56 429
Kartik Viswanathan United States 11 186 0.9× 80 0.5× 109 1.0× 145 1.4× 74 0.8× 28 423
Keum Ha Choi South Korea 13 134 0.7× 122 0.8× 137 1.2× 107 1.0× 112 1.2× 48 443

Countries citing papers authored by Valentina Tateo

Since Specialization
Citations

This map shows the geographic impact of Valentina Tateo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Tateo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Tateo more than expected).

Fields of papers citing papers by Valentina Tateo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Tateo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Tateo. The network helps show where Valentina Tateo may publish in the future.

Co-authorship network of co-authors of Valentina Tateo

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Tateo. A scholar is included among the top collaborators of Valentina Tateo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Tateo. Valentina Tateo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tateo, Valentina, Joep J. de Jong, Brigida Anna Maiorano, et al.. (2025). Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 31(16). 3503–3511.
3.
4.
5.
Tateo, Valentina, Costantino Ricci, Elisa Tassinari, et al.. (2025). Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma. Clinical Genitourinary Cancer. 23(6). 102444–102444.
6.
7.
Tateo, Valentina, Scott M. Gilbert, Victoria K. Cortessis, et al.. (2024). Epidemiology and Risk Factors for Testicular Cancer: A Systematic Review. European Urology. 87(4). 427–441. 9 indexed citations
8.
Gupta, Shilpa, Philippe E. Spiess, Ashish M. Kamat, et al.. (2024). The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies. Critical Reviews in Oncology/Hematology. 200. 104420–104420. 3 indexed citations
9.
10.
Necchi, Andrea, et al.. (2024). Nature and distribution of methyl thioadenosine phosphorylase (MTAP) genomic loss in human tumors.. Journal of Clinical Oncology. 42(16_suppl). 3067–3067. 2 indexed citations
11.
12.
Basile, Giuseppe, Daniele Raggi, Valentina Tateo, et al.. (2024). First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. 42(4_suppl). 610–610. 1 indexed citations
13.
Villatore, Andrea, Valentina Tateo, Davide Vignale, et al.. (2024). Myocarditis Following Pembrolizumab Plus Axitinib, and Belzutifan Plus Lenvatinib for Renal Cell Carcinoma: A Case Report. Cardiovascular Toxicology. 24(11). 1168–1173. 1 indexed citations
14.
Moschini, Marco, Valentina Tateo, Renzo Colombo, et al.. (2024). Perioperative sacituzumab govitecan (SG) alone or in combination with pembrolizumab (Pembro) for patients with muscle-invasive urothelial bladder cancer (MIBC): SURE-01/02 interim results.. Journal of Clinical Oncology. 42(17_suppl). LBA4517–LBA4517. 6 indexed citations
15.
Ricci, Costantino, Francesca Ambrosi, Francesca Giunchi, et al.. (2023). FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal‐type. Histopathology. 83(3). 465–476. 10 indexed citations
16.
17.
Tateo, Valentina, et al.. (2023). Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics. Pharmaceuticals. 16(4). 614–614. 51 indexed citations
18.
Rosellini, Matteo, Elisa Tassinari, Andrea Marchetti, et al.. (2023). An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma. Expert Opinion on Drug Safety. 22(4). 279–291. 4 indexed citations
19.
Ricci, Claudio, Davide Campana, Carlo Ingaldi, et al.. (2023). Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis. Langenbeck s Archives of Surgery. 408(1). 65–65. 2 indexed citations
20.
Tateo, Valentina, Lisa Manuzzi, Andrea De Giglio, et al.. (2020). Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. 21(23). 9056–9056. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann W. Gramza Breakdown of academic impact, for papers by Darren M. Kocs Breakdown of academic impact, for papers by Jinan Ma Breakdown of academic impact, for papers by Zhaofei Pang Breakdown of academic impact, for papers by Maria Antonietta Satolli Breakdown of academic impact, for papers by Fenglong Bie Breakdown of academic impact, for papers by Mitsuro Fukuhara Breakdown of academic impact, for papers by Matías Chacón Breakdown of academic impact, for papers by Kartik Viswanathan Breakdown of academic impact, for papers by Keum Ha Choi
Rankless by CCL
2026